SEC Form 4 · accession 0000905148-18-000728
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Langer
Director
Period of report
Aug 15, 2018
Accepted (ET)
Aug 17, 2018 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 15, 2018 | S | 23,810 | $16.00 | D | 47,978 | I | Langer Family Holdings, LLLP |
| Common Stock | Aug 15, 2018 | S | 14,531 | $16.00 | D | 29,064 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2018.
- F2The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP.